Sectra AB (publ)

ST:SECT-B Sweden Medical Devices
Market Cap
$3.63 Billion
Skr40.73 Billion SEK
Market Cap Rank
#3497 Global
#13 in Sweden
Share Price
Skr226.80
Change (1 day)
-2.58%
52-Week Range
Skr176.20 - Skr372.00
All Time High
Skr372.00
About

Sectra AB (publ) provides solutions for medical IT and cybersecurity sectors in Sweden, the United Kingdom, the Netherlands, and rest of Europe. The company operates through Imaging IT Solutions, Secure Communications, and Business Innovation segments. The Imaging IT Solutions segment develops and sells medical IT systems and services for managing, archiving, and presenting various types of medic… Read more

Sectra AB (publ) (SECT-B) - Net Assets

Latest net assets as of October 2025: Skr1.79 Billion SEK

Based on the latest financial reports, Sectra AB (publ) (SECT-B) has net assets worth Skr1.79 Billion SEK as of October 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr3.50 Billion) and total liabilities (Skr1.71 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets Skr1.79 Billion
% of Total Assets 51.13%
Annual Growth Rate 11.27%
5-Year Change 114.02%
10-Year Change 251.32%
Growth Volatility 20.53

Sectra AB (publ) - Net Assets Trend (2002–2025)

This chart illustrates how Sectra AB (publ)'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Sectra AB (publ) (2002–2025)

The table below shows the annual net assets of Sectra AB (publ) from 2002 to 2025.

Year Net Assets Change
2025-04-30 Skr1.92 Billion +22.12%
2024-04-30 Skr1.57 Billion +21.05%
2023-04-30 Skr1.30 Billion +19.98%
2022-04-30 Skr1.08 Billion +20.67%
2021-04-30 Skr895.62 Million +9.59%
2020-04-30 Skr817.21 Million +12.27%
2019-04-30 Skr727.91 Million +20.12%
2018-04-30 Skr606.00 Million +9.28%
2017-04-30 Skr554.51 Million +1.63%
2016-04-30 Skr545.60 Million -10.82%
2015-04-30 Skr611.77 Million +0.01%
2014-04-30 Skr611.70 Million -8.06%
2013-04-30 Skr665.30 Million -15.51%
2012-04-30 Skr787.39 Million +38.25%
2011-04-30 Skr569.54 Million -5.48%
2010-04-30 Skr602.57 Million +0.58%
2009-04-30 Skr599.11 Million +6.86%
2008-04-30 Skr560.67 Million +7.94%
2007-04-30 Skr519.41 Million +6.76%
2006-04-30 Skr486.50 Million +12.97%
2005-04-30 Skr430.65 Million +10.29%
2004-04-30 Skr390.47 Million +89.48%
2003-04-30 Skr206.07 Million +25.24%
2002-04-30 Skr164.55 Million --

Equity Component Analysis

This analysis shows how different components contribute to Sectra AB (publ)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 3393.5% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (April 2025)

Component Amount Percentage
Retained Earnings Skr1.41 Billion 73.68%
Common Stock Skr39.02 Million 2.04%
Other Comprehensive Income Skr103.92 Million 5.42%
Other Components Skr361.47 Million 18.86%
Total Equity Skr1.92 Billion 100.00%

Sectra AB (publ) Competitors by Market Cap

The table below lists competitors of Sectra AB (publ) ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Sectra AB (publ)'s equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 1,569,591,000 to 1,916,825,000, a change of 347,234,000 (22.1%).
  • Net income of 563,371,000 contributed positively to equity growth.
  • Share repurchases of 211,935,000 reduced equity.
  • Other comprehensive income decreased equity by 47,527,000.
  • Other factors increased equity by 43,325,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income Skr563.37 Million +29.39%
Share Repurchases Skr211.94 Million -11.06%
Other Comprehensive Income Skr-47.53 Million -2.48%
Other Changes Skr43.33 Million +2.26%
Total Change Skr- 22.12%

Book Value vs Market Value Analysis

This analysis compares Sectra AB (publ)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 22.80x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 229.75x to 22.80x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2002-04-30 Skr0.99 Skr226.80 x
2003-04-30 Skr1.22 Skr226.80 x
2004-04-30 Skr2.30 Skr226.80 x
2005-04-30 Skr2.31 Skr226.80 x
2006-04-30 Skr2.61 Skr226.80 x
2007-04-30 Skr2.78 Skr226.80 x
2008-04-30 Skr2.98 Skr226.80 x
2009-04-30 Skr3.19 Skr226.80 x
2010-04-30 Skr3.21 Skr226.80 x
2011-04-30 Skr3.03 Skr226.80 x
2012-04-30 Skr4.18 Skr226.80 x
2013-04-30 Skr3.52 Skr226.80 x
2014-04-30 Skr3.21 Skr226.80 x
2015-04-30 Skr3.21 Skr226.80 x
2016-04-30 Skr2.85 Skr226.80 x
2017-04-30 Skr2.89 Skr226.80 x
2018-04-30 Skr3.15 Skr226.80 x
2019-04-30 Skr3.78 Skr226.80 x
2020-04-30 Skr4.24 Skr226.80 x
2021-04-30 Skr4.65 Skr226.80 x
2022-04-30 Skr5.61 Skr226.80 x
2023-04-30 Skr6.73 Skr226.80 x
2024-04-30 Skr8.15 Skr226.80 x
2025-04-30 Skr9.95 Skr226.80 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Sectra AB (publ) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 29.39%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 17.39%
  • • Asset Turnover: 0.86x
  • • Equity Multiplier: 1.96x
  • Recent ROE (29.39%) is above the historical average (21.28%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2002 24.55% 9.86% 1.13x 2.20x Skr23.96 Million
2003 25.88% 10.59% 1.07x 2.29x Skr32.71 Million
2004 5.34% 4.24% 0.78x 1.62x Skr-18.31 Million
2005 12.58% 11.88% 0.65x 1.62x Skr11.11 Million
2008 9.00% 6.79% 0.75x 1.76x Skr-5.60 Million
2009 8.42% 5.84% 0.86x 1.68x Skr-9.46 Million
2010 2.86% 1.99% 0.89x 1.61x Skr-43.05 Million
2011 -1.69% -1.23% 0.84x 1.64x Skr-66.57 Million
2012 49.00% 46.87% 0.73x 1.44x Skr307.08 Million
2013 9.36% 7.62% 0.75x 1.63x Skr-4.28 Million
2014 16.98% 12.16% 0.85x 1.65x Skr42.69 Million
2015 20.61% 13.11% 0.88x 1.78x Skr64.90 Million
2016 23.04% 11.71% 0.97x 2.02x Skr71.14 Million
2017 27.55% 13.39% 0.98x 2.10x Skr97.33 Million
2018 32.72% 15.65% 1.03x 2.04x Skr137.66 Million
2019 27.34% 14.08% 1.08x 1.81x Skr126.19 Million
2020 29.04% 14.29% 1.10x 1.85x Skr155.63 Million
2021 30.76% 16.88% 0.99x 1.84x Skr185.95 Million
2022 29.13% 16.15% 0.89x 2.03x Skr206.72 Million
2023 28.92% 15.95% 0.86x 2.11x Skr245.29 Million
2024 27.29% 14.45% 0.92x 2.05x Skr271.43 Million
2025 29.39% 17.39% 0.86x 1.96x Skr371.69 Million

Industry Comparison

This section compares Sectra AB (publ)'s net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $75,200,026
  • Average return on equity (ROE) among peers: -74.39%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Sectra AB (publ) (SECT-B) Skr1.79 Billion 24.55% 0.96x $3.63 Billion
Acarix A/S (ACARIX) $76.60 Million -60.65% 0.08x $28.86 Million
Arcoma AB (ARCOMA) $12.52 Million -92.85% 4.66x $8.93 Million
Bactiguard Holding AB (publ) (BACTI-B) $353.18 Million -39.18% 0.87x $19.20 Million
CellaVision AB (CEVI) $20.07 Million 13.08% 1.20x $262.59 Million
Clinical Laserthermia Systems AB (publ) (CLS-B) $65.69 Million -72.50% 0.20x $13.78 Million
Chordate Medical Holding AB (CMH) $38.95 Million -55.88% 0.13x $17.64K
Coala Life Group AB (COALA) $52.33 Million -287.99% 0.53x $468.93K
C-Rad AB (publ) (CRAD-B) $93.64 Million 22.63% 0.57x $56.67 Million
Duearity AB (DEAR) $-2.39 Million 0.00% 0.00x $34.43K
Episurf Medical AB (publ) (EPIS-B) $41.40 Million -170.53% 0.39x $5.40 Million